← Back to Episodes
PODCAST

Your Brain, Your Ovaries, and a Woman Named Kwaneta

September 24, 2026·8:40·Episode 131

Quick Summary

A new Nature study uses blood protein analysis to connect the menopause transition directly to brain aging and dementia risk — and points to a possible intervention window. WIRED reports on surprising new research showing the post-menopausal ovary is still biologically active, which upends a lot of assumptions. And the story of Kwaneta Harris, who built a menopause support network inside a Texas prison using handwritten notes, is a sharp reminder of who gets left out when menopause care requires resources to access.

Your Brain, Your Ovaries, and a Woman Named Kwaneta

0:000:00

Key Takeaways

  • ✦A Nature study found that proteins in the blood shift measurably during menopause in ways that track with faster brain aging and higher dementia risk — and researchers think the perimenopause window may be when intervention matters most.
  • ✦The study used proteomics — analysis of thousands of proteins in the blood — to map these changes, which is a more detailed look at what's happening biologically than most prior menopause-brain research.
  • ✦New research shows the ovary continues producing hormones and other biological signals after menopause, which contradicts the long-held assumption that it essentially shuts down.
  • ✦Kwaneta Harris built a menopause support and education network inside a Texas prison using handwritten notes passed between incarcerated women — because no formal resources existed for them.
  • ✦Incarcerated women are among the most medically underserved populations during menopause, with little to no access to specialist care, hormone therapy, or even basic information.

Episode Script

Thanks Toni. We've got a genuinely interesting mix today — let's get into it.

That Nature study I teased at the top is called a proteomics study, which sounds technical, so let me just tell you what it actually means. Proteomics is the analysis of proteins in the blood — and your blood contains thousands of them. Different proteins are present in different amounts depending on what's happening in your body at any given time. Researchers can now read that protein landscape in a lot of detail and start to see patterns.

What this team did was look at how those blood proteins change during the menopause transition — and then map those changes against markers of brain aging and dementia risk. What they found is that the shift isn't subtle. The changes in blood proteins during perimenopause and menopause correspond to measurable acceleration in brain aging. Not "might be loosely associated." Directly mapped.

Now, before anyone spirals — this is not a study that says menopause causes dementia. That's not what the data shows and it's not what the researchers are claiming. What it shows is that the biological transition of menopause appears to affect the brain in ways we can now measure more precisely than before. That's actually progress. Because for a long time, the brain-menopause connection was something researchers suspected but couldn't pin down cleanly.

The part of this I find most significant is the timing question. The researchers point to perimenopause — the transition period itself, not just post-menopause — as a potentially critical window. The idea being that if you're going to do something to protect brain health, earlier in the transition may matter more than waiting until everything has already shifted. That's not a proven clinical recommendation yet. But it does push back pretty hard against the "wait and see" approach that a lot of women are still being told to take when they first start having symptoms.

The study was published in Nature, which is about as high-profile as scientific journals get. That doesn't make it automatically correct, but it does mean it went through serious peer review. This is the kind of research that shows up in clinical reference tools — the evidence your doctor would look at on something like OpenEvidence when they're trying to get up to speed on the latest. Whether it changes clinical practice soon is a different question. But it adds real weight to the argument that the menopause transition is not a cosmetic inconvenience. It has long-term biological consequences, and it deserves to be treated that way.


WIRED ran a piece this week that I genuinely did not see coming, and I mean that in the best way. The headline: the ovary is surprisingly active after menopause, and scientists are trying to figure out why.

Most of us — and honestly, most of medicine until fairly recently — have thought of the post-menopausal ovary as essentially done. It stopped releasing eggs. Estrogen production dropped dramatically. Story over. Turns out that is not the full story.

What researchers are finding is that the ovary keeps doing things after menopause. It's still producing some hormones. It's still biologically active in ways that affect other systems in the body. The exact mechanisms and the full implications are still being worked out — this is genuinely active, early-stage science — but the basic finding that the ovary doesn't just go dark is already causing people to rethink some assumptions.

One of the more interesting threads in the WIRED piece is the question of what this means for how we've been studying menopause. If we assumed the ovary was inactive and designed research around that assumption, some of those studies may have missed something. That's not a knock on the researchers — you can only work with what you know at the time. But it does suggest that the biology here is more complicated and more dynamic than the textbook version.

For listeners, I'd hold this one loosely for now. Not because it's not credible — the researchers involved are serious people — but because "we're still figuring out why" is an honest description of where the science is. This isn't a finding that changes what you should do tomorrow. It's a finding that changes how scientists are going to be asking questions for the next decade. And that matters, because better questions lead to better answers, and women in perimenopause and post-menopause have been waiting a long time for better answers.

What I'll say directly: the assumption that the ovary is inert after menopause has shaped everything from hormone therapy research to how gynecological care is structured after a certain age. If that assumption is wrong — even partially — then some of the clinical guidance built on top of it deserves a second look. That's worth paying attention to.


The third story today is different in register, and I want to give it the space it deserves.

Kwaneta Harris is an incarcerated woman in a Texas prison. She went through menopause while incarcerated, with no specialist care, no reliable information, and no community around her who understood what was happening. So she built one herself.

She started writing notes — handwritten, on scraps of paper — and passing them to other women in the facility. Information about what menopause is. What symptoms to expect. What was normal and what wasn't. She turned those notes into a support network inside the prison walls, for women who had no other access to any of this.

The story ran on Yahoo News and it's been circulating because it's the kind of thing that makes you stop.

Incarcerated women are one of the most medically underserved populations in the country. The healthcare available inside prisons is inconsistent at best and genuinely inadequate in most cases. Menopause specialist care — rare enough for women on the outside with insurance and a good primary care doctor — is essentially nonexistent inside. Women going through perimenopause and menopause in prison are often managing severe symptoms with no explanation for what's happening to their bodies and no path to treatment.

Kwaneta's solution was to do what humans do when systems fail them: she used what she had. Paper. A pen. Other women. She is not a doctor or a researcher or a health educator. She is someone who understood something important and passed it on because passing it on was the only thing available to her.

The menopause conversation has gotten a lot more visible in the last few years. There are podcasts. There are clinics. There are telehealth platforms. There are influencers and supplement brands and a growing market of products aimed at women in this transition. And all of that reaches a fairly specific slice of women — those with internet access, disposable income, time, and healthcare options.

Kwaneta's story is a reminder that the slice of women the conversation is NOT reaching is large. And the gap isn't about awareness or marketing. It's structural. It's about who has access to healthcare at all, and who is considered worth serving.

The fact that it took handwritten notes passed through a prison to get women there basic menopause information is not a heartwarming bootstrap story. It's an indictment of a system that treated those women as invisible. Kwaneta did something remarkable. She should not have had to.


Sources curated automatically by the Hot Flasher pipeline.

Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.